Saurabh Saha, Chief Executive Officer at Centessa Pharmaceuticals plc (CNTA), sold 110,000 shares at $17.44 ($1.9M) on 2024-12-20, disclosed to the SEC on 2024-12-20.
Scheduled sale ($1.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.44 | 55,000 | $959K | 50.0% |
| 2 | $17.44 | 55,000 | $959K | 50.0% |
| Total | $17.44 avg | 110,000 | $1.9M | 100% |
| Filing → |
| CNTA | SELL | 2025-05-20 | $699K | — | Filing → |
| CNTA | SELL | 2025-04-22 | $1.4M | — | Filing → |
| CNTA | SELL | 2025-03-21 | $1.8M | — | Filing → |